Biotechnology Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors – Candel Therapeutics (NASDAQ:CADL) Read more
Biotechnology NanoViricides (NASDAQ: NNVC) Hits Key Milestones For Its Virus-Fighting Drug Candidate NV-387 In 2023; More To Come This Year – Nanoviricides (AMEX:NNVC) Read more
Biotechnology First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease – First Wave BioPharma (NASDAQ:FWBI) Read more
Biotechnology Genetic Medicines Focused-Ionis Pharmaceuticals’ Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows – Ionis Pharmaceuticals (NASDAQ:IONS) Read more
Biotechnology Acelyrin’s Lead Drug Candidate Hits Primary Goal In Late-Stage Psoriatic Arthritis Study – Acelyrin (NASDAQ:SLRN) Read more
Biotechnology Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone – Invesco Dorsey Wright Financial Momentum ETF (NASDAQ:PFI), Biodexa Pharmaceuticals (NASDAQ:BDRX) Read more
Biotechnology Allergic Reaction Focused ARS Pharmaceuticals’ Lead Candidate Shows Efficacy In Skin Disorder – ARS Pharmaceuticals (NASDAQ:SPRY) Read more
Biotechnology Tharimmune’s Oral ‘Under The Cheek’ Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver Disease – Tharimmune (NASDAQ:THAR) Read more
Biotechnology Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate – Windtree Therapeutics (NASDAQ:WINT) Read more